HarmonyRx

JOIN OUR WEBINAR: Cardiovascular Medications Are Entering a New Era Over the next several years, a growing number of brand-name cardiovascular therapies will become available as generics, creating new opportunities to improve patient access while reducing pharmacy costs. Are you prepared to take advantage of these changes? Join HarmonyRx for our educational webinar: The Next Wave of Cardiovascular Generics: What Employers Need to Know 📅 Date: October 26, 2026 🕒 Time: 1:00 – 1:45 PM ET 💻 Location: Live Webinar Register Now →https://lnkd.in/drf_dT6Y/?utm_campaign=Boost_Post_Engagement_Oct20,2026&utm_source=linkedin&utm_medium=paid&utm_id=1235818814&hsa_acc=519040050&hsa_cam=1235818814&hsa_grp=903959464&hsa_ad=1605871304&hsa_net=linkedin&hsa_ver=3 This educational session will explore how recent and upcoming generic launches are reshaping cardiovascular care and what employers, brokers and consultants should know as they evaluate their pharmacy benefit strategy. During this webinar, you'll learn: • Which cardiovascular medications have recently become available as generics • Upcoming generic launches and patent expirations to watch • How generic competition is reducing pharmacy spend • Clinical considerations for heart failure, acute coronary syndrome (ACS), pulmonary arterial hypertension (PAH) and peripheral arterial disease (PAD) • Strategies to balance cost savings with quality patient care • What these market changes mean for your pharmacy benefits plan Learn more at https://lnkd.in/ei6G8uVP/?utm_campaign=Boost_Post_Engagement_Oct20,2026&utm_source=linkedin&utm_medium=paid&utm_id=1235818814&hsa_acc=519040050&hsa_cam=1235818814&hsa_grp=903959464&hsa_ad=1605871304&hsa_net=linkedin&hsa_ver=3 #Healthcare #Benefits #PharmacyBenefits #Brokers #Consultants #HarmonyRx

LAST CHANCE TO REGISTER! Is the high-rebate PBM model coming to an end? The pharmacy benefits landscape is changing. The Inflation Reduction Act, biosimilar competition and evolving manufacturer pricing are reshaping the economics behind traditional PBM contracts. Join HarmonyRx for an educational webinar: 🎙️ The Future of PBM Contracting: Is the High-Rebate Model Coming to an End? Featuring: Phil Bruns, Sales Director, HarmonyRx Anu Dhamecha, PharmD, The MJ Companies 📅 Thursday, October 15, 2026 ⏰ 1:00 – 1:30 PM ET 💻 Live Webinar 👉 Register today: https://lnkd.in/eTtj_2GR/?utm_campaign=Boost_Post_BrandAwareness_Oct13,2026&utm_source=linkedin&utm_medium=paid&utm_id=1232017894&hsa_acc=519040050&hsa_cam=1232017894&hsa_grp=903421574&hsa_ad=1595656064&hsa_net=linkedin&hsa_ver=3 During this 30-minute discussion, we'll explore: • How the Inflation Reduction Act is influencing pharmacy pricing • The difference between High-WAC and Low-WAC models • Why rebate guarantees are becoming more challenging • How biosimilars are changing the marketplace • What employers, brokers and consultants should be asking their PBM • Why total net cost is becoming an increasingly important measure of value Plus, every registrant will receive our exclusive white paper, The Future of PBM Contracting: Is the High-Rebate Model Coming to an End?, following the event. If you're evaluating your PBM relationship, preparing for an upcoming renewal or looking to stay ahead of a rapidly changing pharmacy benefits market, this is a conversation you won't want to miss. #HarmonyRx #PBM #PharmacyBenefits #EmployeeBenefits #PBMContracting #Biosimilars #InflationReductionAct #Healthcare #BenefitsStrategy

🏆 A proud moment for HarmonyRx! It’s official! Joseph N. Savasta, CEO of HarmonyRx, has received the 2026 PBMI Innovator of the Year Award. This recognition celebrates Joe’s leadership, vision and commitment to challenging the traditional pharmacy benefit model and building a better approach centered on transparency, clinical integrity and long-term value. Joe has remained focused on a simple belief: pharmacy benefits can and should work better for employers, members and the people who serve them. We’re incredibly proud to see that commitment recognized by the industry. Congratulations, Joe, on this well-deserved honor! 👏 🎥Watch the moment: https://lnkd.in/e-xiHiAY/?utm_campaign=Boost_Post_Engagement_Oct1,2026&utm_source=linkedin&utm_medium=paid&utm_id=1215605504&hsa_acc=519040050&hsa_cam=1215605504&hsa_grp=901212894&hsa_ad=1585226164&hsa_net=linkedin&hsa_ver=3 #HarmonyRx #PBMI2026 #InnovatorOfTheYear #PharmacyBenefits #PBM #PBO #HealthcareInnovation #Leadership

Are rebates losing their place as the primary measure of PBM value? The pharmacy benefits landscape is changing rapidly. The Inflation Reduction Act, biosimilars and evolving manufacturer pricing are reshaping how employers evaluate pharmacy benefit strategies. As rebate guarantees become less predictable, organizations need to look beyond rebates and focus on total net cost. Join us for our upcoming webinar: 📅 The Future of PBM Contracting: Is the High-Rebate Model Coming to an End? Date: Thursday, October 15, 2026 at 1:00 PM ET Featuring: Phil Bruns, Sales Director, HarmonyRx, and Anu Dhamecha, PharmD, The MJ Companies. Reserve Your Spot Today: https://lnkd.in/eTtj_2GR/?utm_campaign=Boost_Post_Engagement_Sep29,2026&utm_source=linkedin&utm_medium=paid&utm_id=1215205234&hsa_acc=519040050&hsa_cam=1215205234&hsa_grp=900892044&hsa_ad=1578706404&hsa_net=linkedin&hsa_ver=3 Our experts will discuss: ✔ How the Inflation Reduction Act is changing pharmacy pricing ✔ High-WAC vs. Low-WAC contracting models ✔ Why rebate guarantees are becoming more challenging ✔ How biosimilars are transforming the marketplace ✔ What employers, brokers and consultants should be asking their PBM ✔ Why total net cost is becoming the new benchmark for value 📘 Exclusive Bonus: Everyone who registers will receive our new white paper, The Future of PBM Contracting: Is the High-Rebate Model Coming to an End? This in-depth resource expands on the webinar with additional market insights, practical guidance and strategies you can use long after the session ends. Whether you're reviewing your current PBM contract or preparing for future renewals, this webinar will help you better understand the forces shaping pharmacy benefits today. #PharmacyBenefits #PBM #HealthcareBenefits #EmployeeBenefits #SelfFunded #Biosimilars #InflationReductionAct #HealthcareCosts #BenefitsConsulting #HarmonyRx

33 MINUTES! That's how long it took for the HarmonyRx team to step in, investigate and resolve an urgent specialty medication issue that could have interrupted a member's therapy. The member called at 8:01 a.m. with a serious concern. A duplicate fill had created confusion at the pharmacy level, leaving the patient with just one pill remaining and no clear path forward. The medication involved carried a plan cost of more than $3,800, making a timely resolution critical. By 8:34 a.m., the issue had been reviewed, escalated and resolved. At HarmonyRx, pharmacy benefits are about more than processing claims. They're about protecting patients and ensuring members receive the support they need when it matters most. This is what clinically driven pharmacy management looks like: ✔ Issue identified and resolved in 33 minutes ✔ Real people advocating for members ✔ Hands-on problem solving ✔ Urgent support during critical situations ✔ A commitment to preventing unnecessary delays in care Because pharmacy benefits shouldn't stop at approvals. They should deliver real support, real accountability and real results for the people relying on them every day. Learn more at https://www.harmonyrx.com/ #HarmonyRx #PBM #PBO #PatientCare #HealthcareTransparency #SpecialtyPharmacy #MemberExperience #ClinicalSupport

Cardiovascular Medications Are Entering a New Era Over the next several years, a growing number of brand-name cardiovascular therapies will become available as generics, creating new opportunities to improve patient access while reducing pharmacy costs. Are you prepared to take advantage of these changes? Join HarmonyRx for our educational webinar: The Next Wave of Cardiovascular Generics: What Employers Need to Know 📅 Date: September 9, 2026 🕒 Time: 1:00 – 1:30 PM ET 💻 Location: Live Webinar Register Now → https://lnkd.in/esX_vkc5 This educational session will explore how recent and upcoming generic launches are reshaping cardiovascular care and what employers, brokers and consultants should know as they evaluate their pharmacy benefit strategy. During this webinar, you'll learn: • Which cardiovascular medications have recently become available as generics • Upcoming generic launches and patent expirations to watch • How generic competition is reducing pharmacy spend • Clinical considerations for heart failure, acute coronary syndrome (ACS), pulmonary arterial hypertension (PAH) and peripheral arterial disease (PAD) • Strategies to balance cost savings with quality patient care • What these market changes mean for your pharmacy benefits plan